Evaluation of 1-year vs shorter durations of adjuvant trastuzumab among patients with early breast cancer: an individual participant data and trial-level meta-analysis - Gulia, S; Kannan, S; Badwe, R; Gupta, S (JAMA Netw Open, 2020)